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ABSTRACT
Human MRG15 is a transcription factor that plays a
vital role in embryonic development, cell prolifera-
tion and cellular senescence. It comprises a putative
chromo domain in the N-terminal part that has been
shown to participate in chromatin remodeling and
transcription regulation. We report here the crystal
structure of human MRG15 chromo domain at 2.2 s
resolution. The MRG15 chromo domain consists
of a b-barrel and a long a-helix and assumes a
structure more similar to the Drosophila MOF
chromo barrel domain than the typical HP1/Pc
chromo domains. The b-barrel core contains a hydro-
phobic pocket formed by three conserved aromatic
residues Tyr26, Tyr46 and Trp49 as a potential
binding site for a modified residue of histone tail.
However, the binding groove for the histone tail
seen in the HP1/Pc chromo domains is pre-occupied
by an extra b-strand. In vitro binding assay results
indicate that the MRG15 chromo domain can bind
to methylated Lys36, but not methylated Lys4, Lys9
and Lys27 of histone H3. These data together sug-
gest that the MRG15 chromo domain may function
as an adaptor module which can bind to a modified
histone H3 in a mode different from that of the
HP1/Pc chromo domains.
INTRODUCTION
MORF4 (mortality factor on chromosome 4), MRG15
(MORF4-related gene on chromosome 15) and MRGX
(MORF4-related gene on chromosome X) are members of
the MRG protein family that were ﬁrst identiﬁed as transcrip-
tion factors involved in cellular senescence (1,2). Among
those MRG proteins, MRG15 (a 37 kDa protein consisting
of 323 amino acid residues) is of particular interest because
it is expressed in a wide variety of human tissues and its
homologues have been identiﬁed in many other eukaryotes
(2,3). In addition to its involvement in cellular senescence,
MRG15 is found to be crucial in embryonic development
and cell proliferation. Knockout of MRG15 in mice is embry-
onic lethal and exhibits developmental delay (4). Cell
biological and biochemical studies have shown that MRG15
is most likely to function in chromatin remodeling and
transcriptional regulation through participation in two nucleo-
protein complexes, MAF1 and MAF2 (MRG15-associated
factors 1 and 2, respectively) (5). The C-terminal part of
MRG15 has interactions with the tumor suppressor protein
retinoblastoma (Rb) and a novel nuclear protein PAM14
(protein associated with MRG15 of 14 kDa) in MAF1 (6).
It is also involved in interactions with the HDAC (histone
deacetylase) containing transcriptional corepressor mSin3A
and the plant homeodomain zinc ﬁnger protein Pf1 (7). The
N-terminal part of MRG15 interacts with hMOF (human
male absent on ﬁrst) in MAF2 (6). In addition, MRG15 is
associated with a mammalian TRRAP/Tip60 HAT (histone
acetyltransferase) complexthrough protein MRGBP (MRG15/
MRGX-binding protein) (8). Several MRG15 homologues
in other species, such as MRG1 in Caenorhabditis elegans,
MSL3 (male-speciﬁc lethal protein 3) in Drosophila, Eaf3p
(Esa1p-associated factor 3 protein) in Saccharomyces
cerevisiae, Alp13 (altered polarity protein 13) in ﬁssion
yeast, are also found to be part of multi-subunit HAT/
HDAC complexes that are involved in transcriptional regula-
tion through chromatin remodeling (9–17). However, the
exact functions of MRG15 and its homologues in these
complexes and the underlying molecular mechanism(s) are
unknown.
Human MRG15 consists of a putative chromo domain (the
N-terminal residues 1–85) and a conserved MRG domain (the
C-terminal residues 151–323) which are linked together by a
ﬂexible region (residues 86–150) (2). The MRG domain is
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doi:10.1093/nar/gkl989highly conserved among all MRG proteins and the crystal
structure of the MRG domain of human MRG15 has recently
been determined (18,19). It assumes a fold consisting of
mainly a-helices and appears to function as an adaptor
module to interact with other proteins in nuclear protein com-
plexes. Site-directed mutagenesis studies indicate that several
hydrophobic residues form a shallow hydrophobic pocket to
interact with the N-terminal region of PAM14. The exact
function of the chromo domain of MRG15 is not yet well
understood. However, the conservation of the chromo domain
in many MRG15 homologues underscores its functional
importance. Previous biochemical and structural studies
have shown that chromo and chromo-like domains (such as
Tudor and PWWP domains) are involved in recognition
and interaction with histones or other proteins containing
modiﬁed residues (such as methylated lysines or arginines)
in nucleoprotein complexes (such as HAT and HDAC com-
plexes), and play important roles in chromatin remodeling
that leads to transcriptional activation or repression of a
large number of genes [for reviews see (20–23)]. Chromatin-
binding proteins HP1 (heterochromatin-binding protein 1)
and Pc (Polycomb) chromo domains bind to methylated
Lys9 and Lys27 of histone H3 (H3K9 and H3K27), res-
pectively (24–29). The highly related HP1 chromo shadow
domain can interact with numerous proteins containing a
PXVXL motif (30–33). Many of these interactions play an
important role in directing heterochromatin formation and/
or gene silencing (21,30,34). The yeast Eaf3p chromo domain
binds to methylated Lys4 and Lys36 of histone H3 (H3K4
and H3K36) and this interaction links histone deacetylation
to phosphorylation of the RNA polymerase II C-terminal
domain and thus the transcriptional elongation (14–16). The
human CHD1 (chromo-ATPase/helicase DNA-binding pro-
tein 1) double chromo domains cooperate together to bind
to methylated H3K4 (35). A number of Tudor, PWWP and
other chromo-like domains have also been shown to bind to
methylated N-terminal tails of histones or other proteins
(36–40).
To explore its biological function, we determined the
crystal structure of the chromo domain of human MRG15
at 2.2 s resolution, which assumes a structure more similar
to the Drosophila MOF (dMOF) chromo barrel domain
than the typical HP1/Pc chromo domain. Using in vitro bind-
ing assay, we found that the MRG15 chromo domain can
bind to methylated H3K36. The structural and biochemical
data together suggest that the MRG15 chromo domain may
function as an adaptor module to interact with a modiﬁed
histone in a mode different from that of the HP1/Pc chromo
domains.
MATERIALS AND METHODS
Protein expression and purification
The cDNA encoding the chromo domain of human MRG15
(residues 1–90) was cloned into a modiﬁed pET-3D-His
expression vector (Novagen) which adds a His6 tag at the
N-terminus. The plasmid was transformed into Escherichia
coli strain BL21(DE3) (Novagen) and the transformed bacte-
rial cells were cultured at 37 C in Luria–Bertani medium
containing 0.1 mg/ml ampicillin. Protein expression was
induced by adding IPTG into the medium to a ﬁnal con-
centration of 1 mM. The cells were harvested by centri-
fugation at 5000 g for 10 min at 4  C, resuspended in a
lysis buffer (50 mM Tris–HCl, pH 8.0, 500 mM NaCl,
2m Mb-ME and 1 mM PMSF), and then lysed on ice by
sonication. The recombinant protein was puriﬁed ﬁrst with
afﬁnity chromatography using a Ni-NTA superﬂow column
(Qiagen) and further with gel ﬁltration using a Superdex
G75 HiLoad 26/60 column (Amersham). The target protein
was concentrated to  20 mg/ml in a buffer (50 mM Tris–
HCl, pH 8.0 and 50 mM NaCl) by ultra-ﬁltration for
further structural and biochemical studies. To obtain Se-
Met substituted protein suitable for structural determination,
a mutant MRG15 chromo domain containing mutations
I44M and L76M was generated. The Se-Met substituted mut-
ant protein was expressed in E.coli strain B834(DE3)
(Novagen) and puriﬁed using the same methods as for the
native protein.
In vitro binding assay
To explore the potential binding of the MRG15 chromo
domain with histone, we performed in vitro binding assay
of the chromo domain with the histone mixture from calf
thymus. The cNDAs encoding the human MRG15 chromo
domain (residues 1–90), the yeast Eaf3p chromo domain
(residues 1–113) and the mouse HP1a (residues 1–191),
respectively, were cloned into the pGEX-4T1 expression vec-
tor (Amersham) which adds a GST tag at the N-terminus. The
GST-fused proteins were expressed and puriﬁed using stan-
dard methods. An aliquot of 20 mg of the target protein was
ﬁrst incubated with 100 ml of 25% Glutathione–Sepharose
bead slurry (Amersham) for 1 h. After removal of the solu-
tion, the bead was mixed with 100 mg of BSA protein in
1 ml of buffer A (10 mM Na2HPO4, 2.7 mM KCl, 1.8 mM
KH2PO4, 140 mM NaCl, pH 7.4, 1 mM PMSF and 2 mM
DTT) and the mixture was incubated at 4 C for 1 h to
prevent non-speciﬁc binding. Then, 100 mg of the histone
mixture from calf thymus (H9250; Sigma) was added and
incubated at 4 C for 2 h. After centrifugation, the bead was
washed with the binding buffer twice and then with buffer
B (20 mM Tris–HCl, pH 8.0, 1 mM PMSF, 2 mM DTT,
1 mM EDTA, 1% NP-40 and 0.5 M NaCl) four times. The
bound protein was eluted with loading buffer and analyzed
by SDS–PAGE with Coomassie blue staining. The GST
protein was used as a negative control and the mouse HP1a
and the yeast Eaf3p chromo domain as positive controls.
To identify which speciﬁc modiﬁcation of histone the
MRG15 chromo domain binds with, the eluted sample was
electrophoresed and transferred onto PVDF membrane
(Bio-Rad) and then probed with speciﬁc histone antibodies
(Upstate Biotechnology): anti-H3K9me2 (dilution 1:2000),
anti-H3K27me2 (dilution 1:1000), anti-H3K36me2 (dilution
1:2000) and anti-H3K4me3 (dilution 1:1000). HRP-
conjugated secondary antibody (Chemicon) and ECL-advance
western blotting kit (Amersham) were used for exposure
detection.
To further conﬁrm the interaction between the MRG15
chromo domain and the methylated Lys36 of histone
H3, in vitro binding assay was carried out between the
MRG15 chromo domain and di- and tri-methylated H3K36
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Sigma-Aldrich) and the bound peptide was visualized by pep-
tide dot blot analysis. Speciﬁcally,  20 mg of the N-terminal
His-tagged MRG15 chromo domain was ﬁrst bound to
Ni-NTA superﬂow bead slurry (Qiagen) and then incubated
with an excess amount of the H3K36me2/3 peptide (protein/
peptide molar ratio of 1:3) for 2 h. After extensive washing
with buffer A, the protein with bound peptide was eluted
with 30 ml of buffer C (20 mM Tris–HCl, pH 8.0 and
300 mM imidazole). An aliquot of 2 ml of the eluting solution
was spotted onto PVDF membrane, probed with the anti-
H3K36me2 (dilution 1:2000; Upstate) or anti-H3K36me3
(dilution 1:500; Abcam) antibody and visualized using the
same method as described above.
Crystallization and diffraction data collection
Crystallization was performed using hanging drop vapor
diffusion method. Crystals of both native and Se-Met mutant
MRG15 chromo domains were grown at 4 C in drops
containing equal volumes (2 ml) of the protein solution
(20 mg/ml) and the reservoir solution (14% PEG3350 and
0.2 M KNO3) to approximate dimensions of 0.2 · 0.2 ·
0.1 mm
3 in 2 weeks. The diffraction data were collected
from ﬂash-cooled crystals at 100K. The single anomalous
dispersion (SAD) data were collected to 3.0 s resolution
at CHESS (Cornell High Energy Synchrotron Source) beam-
line F2 and the native data to 2.2 s resolution at CHESS
beamline F1. The diffraction data were processed, integrated
and scaled together with HKL2000 (41). Crystals of the
Se-Met MRG15 chromo domain belong to space group R32
and crystals of the native protein belong to space group C2.
The statistics of the diffraction data are summarized in
Table 1.
Structure determination and refinement
The structure of the MRG15 chromo domain was solved
using the SAD method implemented in the program SOLVE
(42). The SAD results revealed two Se-Met sites in an asym-
metric unit corresponding to the two Met residues introduced
by mutagenesis. The SAD phases were improved by statisti-
cal density modiﬁcation including solvent ﬂattening and
histogram matching using the program RESOLVE (43),
increasing the overall ﬁgure-of-merit from 0.45 to 0.75 at
3.0 s resolution. RESOLVE automatically built a partial
model of 52 polyalanines out of 90 residues and a complete
model was manually built using the program O (44).
This model was used as the search model to determine the
initial phases for the 2.2 s resolution native dataset by the
molecular replacement method implemented in the program
CNS (45). Structure reﬁnement was carried out against the
native dataset using CNS. There are six molecules in an
asymmetric unit. Therefore, 6-fold non-crystallographic sym-
metry (NCS) restrains were used at the early stage of reﬁne-
ment, but were released after the structure reﬁnement
converged. The ﬁnal structure reﬁnement was accomplished
with the maximum-likelihood algorithm implemented in the
program REFMAC5 (46). The statistics of the structure
reﬁnement and the quality of structure models are summa-
rized in Table 1.
RESULTS AND DISCUSSION
Structure of the MRG15 chromo domain
The structure of the MRG15 chromo domain was solved
using the SAD method and the structure reﬁnement con-
verged to an R-factor of 22.4% and a free R-factor of
27.3% to 2.2 s resolution (Table 1). There are six MRG15
chromo domain molecules in the asymmetric unit and struc-
tural comparison shows no substantial difference between
the six molecules, except variation of disordered residues at
the N- (usually 5–6 residues) and C-termini (usually 0–6 resi-
dues). The structure of the MRG15 chromo domain is com-
posed of a twisted b-barrel and a C-terminal long a-helix
(Figure 1A). The b-barrel core consists of ﬁve b-strands
(b1–b5); b-strands b3, b4 and b5 are intercalated by two
short 310 helices (h1 and h2). Highly conserved residues
Tyr26, Tyr46 and Trp49 form a hydrophobic pocket at one
end of the b-barrel which appears to be a potential binding
site for a modiﬁed lysine of histone (see Discussion)
(Figure 1A). The long a-helix folds along one side of the
b-barrel. Residues Leu70, Lys72 and Leu76 of the a-helix
form hydrophobic interactions with Leu18 and Phe20 of b1,
Leu24 and Leu25 of b2, and Leu63 of b5. The side chain Nd2
of Asn69 forms a hydrogen bond with the main-chain car-
bonyl of Lys64 (3.0 s), and the side chain Ne2 of Gln73
Table 1. Summary of diffraction data and structure refinement statistics
Peak Native
Statistics of diffraction data
Wavelength (A ˚) 0.9793 0.9124
Resolution range (A ˚)
a 30.0–3.00 50.0–2.20
(3.11–3.00) (2.28–2.20)
Space group R32 C2
Cell parameters
a (A ˚) 79.2 109.5
b (A ˚) 79.2 80.3
c (A ˚) 84.8 81.3
b ( ) 123.9
Observed reflections 43 456 108 140
Unique reflections [I/s(I) > 0] 2144 29 581
Mosaicity 0.43 0.47
Average redundancy 20.3 (17.9) 3.7 (3.2)
Average I/s(I) 29.2 (17.2) 15.8 (3.8)
Completeness (%) 99.4 (100) 99.8 (99.6)
Rmerge(%)
b 8.2 (20.1) 3.2 (22.7)
Statistics of refinement and model
Number of reflections [Fo > 0s(Fo)]
Working set 28 096
Free R set 1485
R-factor (%)
c 22.4
Free R-factor (%) 27.3
Number of residues 483
Number of water molecules 457
Average B-factor of all atoms (A ˚ 2) 52.7
RMS bond lengths (A ˚) 0.014
RMS bond angles ( ) 1.52
Luzzati atomic positional error (A ˚) 0.31
Ramachandran plot (%)
Most favored regions 92.1
Allowed regions 6.7
Generously allowed regions 1.2
Disallowed regions 0
aNumbers in parentheses refer to the highest resolution shell.
bRmerge ¼
P
hkl
P
i jIiðhklÞi  h IðhklÞij=
P
hkl
P
i IiðhklÞ.
cR-factor ¼j j Foj j Fcjj/jFoj.
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These interactions dictate the position and orientation of
the a-helix relative to the b-barrel, forming a large cleft
(Figure 1B).
Comparison with other chromo and
chromo-like domains
Structural comparison indicates that the overall structure of
the MRG15 chromo domain is more similar to that of the
dMOF chromo barrel domain (47) than that of the prototype
HP1/Pc chromo domains (24–29) and the HP1 chromo sha-
dow domain (31–33) (Figure 2). Superposition of the b-barrel
core of the MRG15 chromo domain with that of other chromo
domains reveals an RMSD of 1.6 s with the HP1 chromo
domain (1GUW, 41 Ca atoms), an RMSD of 2.2 s with
the HP1 chromo shadow domain (1S4Z, 35 Ca atoms) and
an RMSD of 1.4 s with the dMOF chromo barrel domain
(2BUD, 49 Ca atoms). The HP1/Pc chromo domains act as
adaptor modules to bind methylated H3K9 or H3K27 in chro-
matin remodeling and transcriptional regulation (24–29). The
histone tail is bound between two b-strands of the b-barrel
and the methylated lysine is bound at a hydrophobic pocket
formed by three conserved aromatic residues (Tyr21, Trp42
and Phe45 in mouse HP1 or Tyr26, Trp47 and Trp50 in
Drosophila Pc). Unlike the HP1/Pc chromo domains, the
HP1 chromo shadow domain forms a homodimer as the func-
tional unit (31–33). Though the chromo shadow domain
shares a similar b-barrel core with the chromo domain, it
binds a PXVXL motif containing peptide in a completely dif-
ferent manner in which the bound peptide is sandwiched
between the extended b-strands from the C-terminus of the
two subunits (33). Different from the HP1/Pc chromo
domains in which the C-terminal region forms an a-helix
ﬂanking the b-barrel core, the C-terminal part of the
MRG15 chromo domain forms a long a-helix against the
b-barrel core in the opposite direction (Figure 2C and D).
The C-terminal part of the dMOF chromo barrel domain
occupies a position similar to that of the MRG15 chromo
domain but forms a short a-helix and an extended coil. Simi-
lar to the dMOF chromo barrel domain, the b-barrel of the
MRG15 chromo domain is in general similar to that of the
HP1/Pc chromo domains but contains an extra b-strand
(b1) which occupies the histone tail binding groove seen in
the HP1/Pc chromo domains (Figure 2C and D). Though
the MRG15 chromo domain also contains a hydrophobic
pocket formed by conserved residues Tyr26, Tyr46 and
Trp49, the binding site for methylated lysine is partially occu-
pied by the side chain of His21 (equivalent to Arg387 of
dMOF) which would have steric conﬂict with the side chain
of methylated Lys9 in the HP1 chromo domain complex
with the H3K9 peptide. Based on the structural similarities
of the MRG15 and dMOF chromo domains and their common
differences with the HP1/Pc chromo domains and the chromo
shadow domain, we suggest that the MRG15 chromo domain
should also be called a chromo barrel domain.
In addition to the chromo domain, several chromo-like
domains involved in chromatin function have been identiﬁed,
including Tudor domain (36–39) and PWWP domain (48).
Structural comparisons of these protein modules (chromo,
Tudor and PWWP domains) indicate that although these
domains have very low sequence similarity (<20% identity)
they share a strong structural similarity to a conserved
b-barrel core and a hydrophobic pocket (Figure 2), suggesting
that they may be evolved from the same ancestor and have
similar biological functions (22,47). Nevertheless, there
are notable structural differences between these domains
(Figure 2C and D). The HP1/Pc chromo domains have a
four-stranded b-barrel; the histone peptide is sandwiched
between two b-strands and the modiﬁed residue is embedded
in a hydrophobic pocket formed by three aromatic residues.
On the other hand, the chromo barrel domains of MRG15
and dMOF, the SMN Tudor domain and the Dnmt3b
PWWP domain have a ﬁve-stranded b-barrel; the putative
binding groove for the histone tail is occupied by an extra
N-terminal b-strand (b1) and the binding pocket for the modi-
ﬁed residue is occupied in part by a residue of b1 (His21 of
MRG15, Arg387 of dMOF, Trp102 of the SMN Tudor and
Ile240 of the Dnmt3b PWWP). Moreover, the three aromatic
residues forming the hydrophobic pocket are less conserved
(Figure 2B). These structural differences might imply that
these domains may use different modes to recognize and
bind their protein substrates.
The MRG15 chromo domain can bind to
methylated H3K36
Chromo domains and chromo-like domains have been shown
to be involved in the binding of modiﬁed histones or other
A
B
Figure 1. Structure of human MRG15 chromo domain. (A) Overall structure.
Left panel: secondary structure elements. Right panel: structure of the potent-
ial binding pocket for a modified residue. Residues forming the pocket are
shown with side chains. (B) Electrostatic surface of the MRG15 chromo
domain. The b-barrel core and the C-terminal a-helix form a large surface
cleft.
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HDAC complexes) and play important functional roles in
chromatin remodeling [for reviews see (20–23)]. The evident
structural similarity of the MRG15 chromo domain to the
other chromo domains implies that it may function as a mod-
ule to interact with a modiﬁed histone. Since the chromo
domain of Eaf3p, the yeast homolog of human MRG15 was
shown to bind directly with methylated H3K4 and H3K36
A
B
CD
Figure 2. Comparison of the MRG15 chromo domain with representative chromo and chromo-like domains. (A) Sequence comparison of the chromo domains
between MRG15 and its homologues in other species. Hs, Homo sapiens; Mm, Mus musculus; Dm, Drosophila melanogaster; Sp, Schizosaccharomyces pombe;
Sc, Saccharomyces cerevisiae; At, Arabidopsis thaliana; and Ce, Caenorhabditis elegans. Strictly conserved residues are highlighted in shaded red boxes and
conserved residues in open red boxes. The secondary structure of the MRG15 chromo domain is placed on top of the alignment. (B) Structure-based sequence
alignment of the MRG15 chromo domain with representative chromo, Tudor and PWWP domains. The secondary structure for the first member of each group is
placed on top of the alignment. Dm_MOF: the dMOF chromo barrel domain, PDB code 2BUD; Mm_MOF: the mouse MOF chromo barrel domain, PDB code
1WGS; Mm_HP1b: the mouse HP1b chromo domain, PDB code 1GUW; Dm_HP1: the Dm HP1 chromo domain, PDB code 1KNA; Dm_Pc: the Dm Pc chromo
domain, PDB code 1PDQ; Sp_CLR4: the Sp CLR4 chromo domain, PDB code 1G6Z; Hs_SMN: the human SMN Tudor domain, PDB code 1G5V; Mm_53BP1:
the mouse 53BP1 Tudor domain, PDB code 1XNI; Aa_NusG: the Aquifex aeolicus transcription factor NusG Tudor domain, PDB code 1M1G; Mm_Dnmt3b: the
mouse Dnmt3b PWWP domain, PDB code 1KHC; Hs_HDGF: the human HDGF domain of hepatoma-derived growth factor (HDGF)-related protein, PDB code
1RIO; Sp_SPBC215: the Sp protein SPBC215 PWWP domain, PDB code 1H3Z; Mm_HRP: the PWWP domain of mouse HDGF-related protein 3, PDB code
1N27. The stars indicate conserved residues that form the hydrophobic pocket in the HP1/Pc chromo domains and the triangle indicates the residue that occupies
in part the hydrophobic pocket. (C) Structural comparison of the MRG15 chromo domain with the dMOF and HP1 chromo domain, the HP1 chromo shadow
domain, the SMN Tudor domain and the Dnmt3b PWWP domain. Residues forming the hydrophobic pocket are shown with side chains and the bound peptides
in the HP1 chromo domain complex and the HP1 chromo shadow domain complex are shown in magenta. (D) Superposition of the MRG15 chromo domain
(red), the dMOF chromo barrel domain (magenta), the HP1 chromo domain (yellow), the SMN Tudor domain (cyan) and the Dnmt3b PWWP domain (green).
The bound histone H3 peptide in complex with the HP1 chromo domain is shown in blue.
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possible. To pursue this notion, we ﬁrst examined whether the
MRG15 chromo domain can bind to any speciﬁc histone. The
GST pull-down assay results showed that the GST-fused
MRG15 chromo domain can bind with histone H3 from the
calf thymus histone mixture and the binding afﬁnity appears
to be relatively weaker than that of the GST-fused HP1
(Figure 3A). To identify which modiﬁed residue(s) of histone
H3 is involved in the binding, the GST pull-down histone
sample was further analyzed using anti-histone antibodies
targeting speciﬁcally at several commonly modiﬁed residues
of histone H3, including methylated Lys4, Lys9, Lys27 and
Lys36 (Figure 3B). Consistent with the literature, the
mouse HP1a can bind to methylated H3K9 and H3K27,
and the yeast Eaf3p chromo domain can bind to methylated
H3K36 and H3K4. Moreover, our results clearly show that
the MRG15 chromo domain can bind to methylated
H3K36, but not methlyated H3K4, H3K9 and H3K27. To
verify the interaction between the MRG15 chromo domain
and the methylated H3K36, we carried out in vitro binding
assay between the MRG15 chromo domain and di- and tri-
methylated H3K36 peptides (H3K36me2/3, residues 28–44)
(Figure 3D). The results indicate that the MRG15 chromo
domain can bind to both H3K36me2 and H3K36me3 pep-
tides, but not the unmethylated H3K36 peptide.
Structural comparison of the MRG15 chromo domain with
the HP1 chromo domain indicate that three conserved
aromatic residues Tyr26, Tyr46 and Trp49 of the MRG15
chromo domain form a hydrophobic pocket, corresponding
to that formed by residues Tyr21, Trp42 and Phe45 of mouse
HP1a which is the binding site of methylated H3K9. Previ-
ous biochemical data have also shown that mutations of
two aromatic residues Tyr81 and Trp84 in the corresponding
hydrophobic pocket of the Eaf3p chromo domain (equivalent
to Trp42 and Phe45 of mouse HP1a, respectively) disrupt
the binding of Eaf3p with methylated H3K36 (16). Thus, it
is possible that the hydrophobic pocket formed by Tyr26,
Tyr46 and Trp49 of the MRG15 chromo domain might also
be the potential binding site for the methylated Lys36 of
histone H3. On the other hand, since the MRG15 chromo
domain has an extra b-strand occupying the histone binding
groove seen in the HP1/Pc chromo domains, it seems very
likely that the MRG15 chromo domain might use other
surface cleft or depression to bind the methylated H3K36.
Besides the canonical peptide binding mode found in the
HP1/Pc chromo domains, different substrate binding modes
have been observed in other chromo domains (33,35). The
crystal structure of the MRG15 chromo domain in complex
with a histone peptide and further biochemical studies will
eventually resolve the exact substrate binding mode of the
A B
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Figure 3. In vitro binding assays showing that the MRG15 chromo domain can bind to methylated H3K36. (A) GST pull-down assays of the GST-fused MRG15
chromo domain (MRG15N) and the mouse HP1a with the calf thymus histone mixture. The protein samples were analyzed by SDS–PAGE with Coomassie blue
staining. The results clearly show that the MRG15 chromo domain can bind to histone H3. (B) Western blot analysis of the GST pull-down samples of the
MRG15 chromo domain (MRG15N), the mouse HP1a and the yeast Eaf3p chromo domain (Eaf3pN) with the calf thymus histone mixture. The mouse HP1a
binds to H3K9me2 and H3K27me2. The yeast Eaf3p chromo domain binds to H3K36me2 and H3K4me3. The MRG15 chromo domain binds to H3K36me2.
GST was used as a negative control. (C) Control experiments showing the specificity of the anti-H3K36me2/3 antibodies. The anti-H3K36me2 antibody has a
high specificity with the H3K36me2 peptide and a weak cross-reaction with the H3K36me3 peptide, but no reaction with the unmethylated H3K36 peptide. The
anti-H3K36me3 antibody recognizes only the H3K36me3 peptide. (D) In vitro binding assays of the N-terminal His-tagged MRG15 chromo domain with the
H3K36me2 and H3K36me3 peptides. The yeast Eaf3p chromo domain (Eaf3pN) was used as a positive control. The results show that the MRG15 chromo
domain can bind to both H3K36me2 and H3K36me3 peptides, but not the unmethylated H3K36 peptide.
6626 Nucleic Acids Research, 2006, Vol. 34, No. 22MRG15 chromo domain and possibly other chromo barrel
domains.
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